iFluor® 488 tyramide
Example protocol
AT A GLANCE
- Fix/permeabilize/block cells or tissue
- Add primary antibody in blocking buffer
- Add HRP-conjugated secondary antibody
- Prepare tyramide working solution and apply in cells or tissue for 5-10 minutes at room temperature
PREPARATION OF STOCK SOLUTIONS
Unless otherwise noted, all unused stock solutions should be divided into single-use aliquots and stored at -20 °C after preparation. Avoid repeated freeze-thaw cycles
Add 100 µL of DMSO to the vial of iFluor® tyramide and mix well.
Note: Make single-use aliquots and store unused 200X stock solution at 2-8 °C, protected from light. Avoid repeat freeze-thaw cycles.
PREPARATION OF WORKING SOLUTION
Add 100 µL of the tyramide stock solution into 20 mL of a buffer of your choice containing 0.003% H2O2.
Note: For optimal performance, use Tris Buffer, pH=7.4.
Note: A 20 mL solution is good for 200 tests. The tyramide working solution should be used immediately and made fresh on the day of use. Avoid direct exposure to light.
Make an appropriate concentration of secondary antibody-HRP working solution per the manufacturer's recommendations.
SAMPLE EXPERIMENTAL PROTOCOL
This protocol is applicable for both cells and tissues staining.
- Fix the cells or tissue with 3.7% formaldehyde or paraformaldehyde, in PBS at room temperature for 20 minutes.
- Rinse the cells or tissue with PBS twice.
- Permeabilize the cells with 0.1% Triton X-100 solution for 1-5 minutes at room temperature.
- Rinse the cells or tissue with PBS twice.
Deparaffinize and dehydrate the tissue according to the standard IHC protocols. Perform antigen retrieval with the preferred specific solution/protocol as needed. A protocol can be found at:
https://www.aatbio.com/resources/guides/paraffin-embedded-tissue-immunohistochemistry-protocol.html
- Optional: Quench endogenous peroxidase activity by incubating cell or tissue sample in peroxidase quenching solution (such as 3% hydrogen peroxide) for 10 minutes. Rinse with PBS twice at room temperature.
- Optional: If using HRP-conjugated streptavidin, it is advisable to block endogenous biotins by biotin blocking buffer.
- Block with preferred blocking solution (such as PBS with 1% BSA) for 30 minutes at 4 °C.
- Remove blocking solution and add primary antibody diluted in recommended antibody diluent for 60 minutes at room temperature or overnight at 4 °C.
- Wash with PBS three times for 5 minutes each.
Apply 100 µL of secondary antibody-HRP working solution to each sample and incubate for 60 minutes at room temperature.
Note: Incubation time and concentration can be varied depending on the signal intensity.
- Wash with PBS three times for 5 minutes each.
Prepare and apply 100 µL of Tyramide working solution to each sample and incubate for 5-10 minutes at room temperature.
Note: If you observe a non-specific signal, you can shorten the incubation time with the tyramide reagent. You should optimize the incubation period using positive and negative control samples at various incubation time points. Or you can use a lower concentration of the tyramide reagent in the working solution.
- Rinse with PBS three times.
- Counterstain the cell or tissue samples as needed. AAT provides a series of nucleus counterstain reagents as listed in Table 1. Follow the instruction provided with the reagents.
Mount the coverslip using a mounting medium with anti-fading properties.
Note: To ensure optimal results, it is recommended to use either ReadiUse™ microscope mounting solution (Cat. 20009) or FluoroQuest™ TSA/PSA Antifade Mounting Medium *Optimized for Tyramide and Styramide Imaging* (Cat. 44890) instead of Vectashield® mounting media. There are instances where Vectashield® mounting media may not be suitable for certain TSA/PSA conjugates.
- Use the appropriate filter set to visualize the signal from the Tyramide labeling.
Table 1. Products recommended for nucleus counterstain
Cat# | Product Name | Ex/Em (nm) |
17548 | Nuclear Blue™ DCS1 | 350/461 |
17550 | Nuclear Green™ DCS1 | 503/526 |
17551 | Nuclear Orange™ DCS1 | 528/576 |
17552 | Nuclear Red™ DCS1 | 642/660 |
Calculators
Common stock solution preparation
0.1 mg | 0.5 mg | 1 mg | 5 mg | 10 mg | |
1 mM | 188.157 µL | 940.787 µL | 1.882 mL | 9.408 mL | 18.816 mL |
5 mM | 37.631 µL | 188.157 µL | 376.315 µL | 1.882 mL | 3.763 mL |
10 mM | 18.816 µL | 94.079 µL | 188.157 µL | 940.787 µL | 1.882 mL |
Molarity calculator
Mass (Calculate) | Molecular weight | Volume (Calculate) | Concentration (Calculate) | Moles | ||||
/ | = | x | = |
Spectrum
Product family
Name | Excitation (nm) | Emission (nm) | Extinction coefficient (cm -1 M -1) | Quantum yield | Correction Factor (260 nm) | Correction Factor (280 nm) |
iFluor® 488 maleimide | 491 | 516 | 750001 | 0.91 | 0.21 | 0.11 |
iFluor® 488 amine | 491 | 516 | 750001 | 0.91 | 0.21 | 0.11 |
iFluor® 488 hydrazide | 491 | 516 | 750001 | 0.91 | 0.21 | 0.11 |
iFluor® 488 azide | 491 | 516 | 750001 | 0.91 | 0.21 | 0.11 |
iFluor® 488 alkyne | 491 | 516 | 750001 | 0.91 | 0.21 | 0.11 |
iFluor® 488 Styramide *Superior Replacement for Alexa Fluor 488 tyramide and Opal 520* | 491 | 516 | 750001 | 0.91 | 0.21 | 0.11 |
iFluor® 555 Tyramide | 557 | 570 | 1000001 | 0.641 | 0.23 | 0.14 |
iFluor® 647 Tyramide | 656 | 670 | 2500001 | 0.251 | 0.03 | 0.03 |
iFluor® 350 Tyramide | 345 | 450 | 200001 | 0.951 | 0.83 | 0.23 |
Show More (10) |
Citations
Authors: G{\'a}mez-Belmonte, Reyes and Wagner, Yara and Mahapatro, Mousumi and Wang, Ru and Erkert, Lena and Gonz{\'a}lez-Acera, Miguel and Cineus, Roodline and Hainbuch, Saskia and Patankar, Jay V and Voehringer, David and others,
Journal: Scientific Reports (2024): 26522
Authors: Niu, Yuanyuan and Liu, Suling and Qiu, Qian and Fu, Di and Xiao, Youjun and Liang, Liuqin and Cui, Yang and Ye, Shanhui and Xu, Hanshi
Journal: Arthritis Research \& Therapy (2024): 184
Authors: Chen, Fangfang and Li, Yixuan and Zhao, Li and Lin, Cong and Zhou, Yingzi and Ye, Wenjing and Wan, Weiguo and Zou, Hejian and Xue, Yu
Journal: International Immunopharmacology (2024): 112942
Authors: Verkerke, Anthony RP and Shi, Xu and Li, Mark and Higuchi, Yusuke and Yamamuro, Tadashi and Katoh, Daisuke and Nishida, Hiroshi and Auger, Christopher and Abe, Ichitaro and Gerszten, Robert E and others,
Journal: Cell Metabolism (2024)
Authors: Lahera, Antonio and Vela-Mart{\'\i}n, Laura and Fern{\'a}ndez-Navarro, Pablo and Llamas, Pilar and L{\'o}pez-Lorenzo, Jos{\'e} L and Cornago, Javier and Santos, Javier and Fern{\'a}ndez-Piqueras, Jos{\'e} and Villa-Morales, Mar{\'\i}a
Journal: npj Precision Oncology (2024): 152
References
Authors: Faget L, Hnasko TS.
Journal: Methods Mol Biol (2015): 161
Authors: Trang NT, Hirai T, Ngan PH, Lan NT, Fuke N, Toyama K, Yamamoto T, Yamaguchi R.
Journal: J Vet Diagn Invest (2015): 326
Authors: Aydin M, Herzig GP, Jeong KC, Dunigan S, Shah P, Ahn S.
Journal: J Food Prot (2014): 100
Authors: Lauter G, Soll I, Hauptmann G.
Journal: Methods Mol Biol (2014): 175
Authors: Garrigues HJ, Rubinchikova YE, Rose TM.
Journal: Virology (2014): 75